Evaluation of a risk score to predict future Clostridium difficile disease using UK primary care and hospital data in Clinical Practice Research Datalink
Author:
Affiliation:
1. GSK, Brentford, UK
2. Valesta c/o GSK, Mechelen, Belgium
3. P95, Heverlee, Belgium
4. Department of Non communicable disease epidemiology, London School of Hygiene & Tropical medicine, London, UK
5. GSK, Wavre, Belgium
Funder
GSK
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://tandfonline.com/doi/pdf/10.1080/21645515.2019.1589288
Reference33 articles.
1. Vaccines againstClostridium difficile
2. Clostridium difficile Infection
3. Public Health England. Updated guidelines on the management and treatment of C. diff infection. 2013. [accessed 2017 May 7]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/321891/Clostridium_difficile_management_and_treatment.pdf.
4. Burden ofClostridium difficileInfection in the United States
5. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Describing the monthly variability of hospital-onset Clostridioides difficile during early coronavirus disease 2019 (COVID-19) using electronic health record data;Infection Control & Hospital Epidemiology;2023-10-09
2. A new score to predict Clostridioides difficile infection in medical patients: a sub-analysis of the FADOI-PRACTICE study;Internal and Emergency Medicine;2023-08-26
3. Clostridium difficile Infection: Risk and Poor Prognostic Factors at a Tertiary Hospital in the Eastern Region of Saudi Arabia;Cureus;2023-05-18
4. Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine;Infection and Drug Resistance;2021-11
5. Can prediction scores be used to identify patients at risk of Clostridioides difficile infection?;Current Opinion in Gastroenterology;2021-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3